480 related articles for article (PubMed ID: 25947159)
1. Immunology of protection from Ebola virus infection.
Krause PR; Bryant PR; Clark T; Dempsey W; Henchal E; Michael NL; Regules JA; Gruber MF
Sci Transl Med; 2015 May; 7(286):286ps11. PubMed ID: 25947159
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-vectored Ebola vaccines.
Gilbert SC
Expert Rev Vaccines; 2015; 14(10):1347-57. PubMed ID: 26289977
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
[TBL] [Abstract][Full Text] [Related]
4. CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.
Sullivan NJ; Hensley L; Asiedu C; Geisbert TW; Stanley D; Johnson J; Honko A; Olinger G; Bailey M; Geisbert JB; Reimann KA; Bao S; Rao S; Roederer M; Jahrling PB; Koup RA; Nabel GJ
Nat Med; 2011 Aug; 17(9):1128-31. PubMed ID: 21857654
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity.
Pinski AN; Messaoudi I
Curr Opin Virol; 2021 Dec; 51():179-189. PubMed ID: 34749265
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse.
O'Brien LM; Stokes MG; Lonsdale SG; Maslowski DR; Smither SJ; Lever MS; Laws TR; Perkins SD
Virology; 2014 Mar; 452-453():324-33. PubMed ID: 24461913
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP
Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432
[TBL] [Abstract][Full Text] [Related]
8. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
[TBL] [Abstract][Full Text] [Related]
9. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
Zhou Y; Sullivan NJ
Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875
[TBL] [Abstract][Full Text] [Related]
10. Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates.
Richardson JS; Pillet S; Bello AJ; Kobinger GP
J Virol; 2013 Apr; 87(7):3668-77. PubMed ID: 23302894
[TBL] [Abstract][Full Text] [Related]
11. A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection.
Choi JH; Jonsson-Schmunk K; Qiu X; Shedlock DJ; Strong J; Xu JX; Michie KL; Audet J; Fernando L; Myers MJ; Weiner D; Bajrovic I; Tran LQ; Wong G; Bello A; Kobinger GP; Schafer SC; Croyle MA
Mol Pharm; 2015 Aug; 12(8):2712-31. PubMed ID: 25363619
[TBL] [Abstract][Full Text] [Related]
12. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
13. Development of vaccines for prevention of Ebola virus infection.
Ye L; Yang C
Microbes Infect; 2015 Feb; 17(2):98-108. PubMed ID: 25526819
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.
Bradfute SB; Anthony SM; Stuthman KS; Ayithan N; Tailor P; Shaia CI; Bray M; Ozato K; Bavari S
PLoS One; 2015; 10(3):e0118434. PubMed ID: 25785602
[TBL] [Abstract][Full Text] [Related]
15. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
[TBL] [Abstract][Full Text] [Related]
16. Characterization of host immune responses in Ebola virus infections.
Wong G; Kobinger GP; Qiu X
Expert Rev Clin Immunol; 2014 Jun; 10(6):781-90. PubMed ID: 24742338
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
Wong G; Richardson JS; Pillet S; Racine T; Patel A; Soule G; Ennis J; Turner J; Qiu X; Kobinger GP
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S379-83. PubMed ID: 25957963
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
Marzi A; Hanley PW; Haddock E; Martellaro C; Kobinger G; Feldmann H
J Infect Dis; 2016 Oct; 214(suppl 3):S360-S366. PubMed ID: 27496978
[TBL] [Abstract][Full Text] [Related]
19. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
[TBL] [Abstract][Full Text] [Related]
20. Impact of systemic or mucosal immunity to adenovirus on Ad-based Ebola virus vaccine efficacy in guinea pigs.
Richardson JS; Abou MC; Tran KN; Kumar A; Sahai BM; Kobinger GP
J Infect Dis; 2011 Nov; 204 Suppl 3():S1032-42. PubMed ID: 21987739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
